Term
|
Definition
Na blocker
local anesthetic |
|
|
Term
|
Definition
COX inhibitor (II > I)
arthritis pain/anti-inflammatory
increased risk for cerebrovascular events |
|
|
Term
|
Definition
|
|
Term
|
Definition
mu-opioid agonist
analgesia |
|
|
Term
|
Definition
PPAR-alpha agonist
hyperlipidemia |
|
|
Term
|
Definition
K-channel antagonist
Sulfonyl-urea
hypoglycemic agent
SE-weight gain |
|
|
Term
|
Definition
K-channel antagonist
Non-sulfonyl-urea
hypoglycemic agent
ROSA |
|
|
Term
|
Definition
PPAR-alpha and gamma
for Type-2 DM
increased risk for heart failure (many side effects and interactions) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| leukotrine receptor inhibitor |
|
|
Term
|
Definition
long acting gluccocorticoid
anti-inflammatory |
|
|
Term
|
Definition
| anti-anxiety, vasodilation |
|
|
Term
|
Definition
|
|
Term
|
Definition
intermediate acting glucocorticoid
anti-inflammatory |
|
|
Term
|
Definition
5HT-4 agonist
gastroparesis |
|
|
Term
|
Definition
|
|
Term
|
Definition
5HT2 antagonists (and Pitzotifen)
psychosis |
|
|
Term
|
Definition
5HT3 antagonist
anti-emesis, diarrhea, IBS |
|
|
Term
|
Definition
|
|
Term
|
Definition
H2 blocker
lower gastric acid |
|
|
Term
|
Definition
VW Class III, K channel blockers
anti-arrhythmic |
|
|
Term
|
Definition
|
|
Term
|
Definition
| BDZ - sedatives; antiseizure |
|
|
Term
|
Definition
anti-psychotic, anti-histamine
antagonist: D2, H1, muscarinic, Na, K, a-1 |
|
|
Term
|
Definition
|
|
Term
|
Definition
Phosphodiesterase III inhibitors
increase cAMP |
|
|
